CCI-779
Jump to navigation
Jump to search
| CCI-779 | |
|---|---|
| Term | CCI-779 |
| Short definition | CCI-779 - A drug used to treat advanced renal cell carcinoma (a type of kidney cancer). It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
CCI-779 - A drug used to treat advanced renal cell carcinoma (a type of kidney cancer). It is also being studied in the treatment of other types of cancer. CCI-779 blocks a protein called mTOR that helps control cell division. Blocking this protein can help prevent cancer cells from growing. CCI-779 is a type of kinase inhibitor. Also called temsirolimus and torisel
External links
- Medical encyclopedia article on CCI-779
- Wikipedia's article - CCI-779
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski